The Lancet Oncology – A Working Group of 20 scientists from 10 countries met at the invitation of the International Agency for Research on Cancer (IARC) to finalise their evaluation of the carcinogenicity of four agents: anthracene, 2-bromopropane, butyl methacrylate (BMA), and dimethyl hydrogen phosphite (DMHP). 2-Bromopropane was classified as “probably carcinogenic to humans” (Group 2A) based on “sufficient” evidence for cancer in experimental animals and “strong” mechanistic evidence in experimental systems. The other three agents were classified as “possibly carcinogenic to humans” (Group 2B) based on “sufficient” evidence for cancer in experimental animals. For all four agents, the evidence regarding cancer in humans was “inadequate”, as no studies were available. These assessments will be published in Volume 133 of the IARC Monographs.
Subscribe to our newsletters
The CAREX Canada team offers two regular newsletters: the biannual e-Bulletin summarizing information on upcoming webinars, new publications, and updates to estimates and tools; and the monthly Carcinogens in the News, a digest of media articles, government reports, and academic literature related to the carcinogens we’ve classified as important for surveillance in Canada. Sign up for one or both of these newsletters below.
School of Population and Public Health
University of British Columbia
370A - 2206 East Mall
Vancouver, BC V6T 1Z3
As a national organization, our work extends across borders into many Indigenous lands throughout Canada. We gratefully acknowledge that our host institution, the University of British Columbia Point Grey campus, is located on the traditional, ancestral and unceded territories of the xʷməθkʷəy̓əm (Musqueam) people.